Professor of Genetic Epidemiology, University of Cambridge
Professor Douglas Easton is a leading genetic epidemiologist with a specific interest in the genetics of hormone related cancers. He graduated in mathematics from the University of Cambridge, and did his PhD in genetic epidemiology at the Institute of Cancer Research. Since 1995 he has been Director of the Centre for Cancer Genetic Epidemiology in Cambridge.
His studies have been instrumental in the characterisation of many cancer susceptibility genes, including BRCA1, BRCA2, CHEK2 and ATM, the identification of several hundred common cancer susceptibility variants, and the development of genetic risk scores. In 2007 he led the first genome-wide association study in breast cancer. Professor Easton leads the Breast Cancer Association Consortium, a collaboration involving more than 100 research groups and 300,000 subjects. He leads the EMBRACE cohort study of BRCA1/2 mutation carriers, and initiated the BOADICEA risk prediction model, now used in genetic counselling worldwide.
In 2008 he was awarded the Inaugural AACR/Susan Komen Outstanding Investigator Award for Breast Cancer Research, and in 2019 he was jointly awarded the Basser Global Prize for BRCA Research.